Mobile-health Network Solutions Class A Ordinary Shares (MNDR) vs XORTX Therapeutics Inc. (XRTX)

A side-by-side comparison of Mobile-health Network Solutions Class A Ordinary Shares and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Mobile-health Network Solutions Class A Ordinary Shares logo
MNDR
Mobile-health Network Solutions Class A Ordinary Shares
$30019
$1.22HealthcareDelayed quote: Oct 6, 2026, 3:14 PM EDT
XORTX Therapeutics Inc. logo
XRTX
XORTX Therapeutics Inc.
$484571
$1.74HealthcareDelayed quote: Oct 6, 2026, 2:56 PM EDT

Total return — MNDR vs XRTX

growth of $100 · dividends reinvested · last 2y
MNDR -100.0% (-98.8%/yr)XRTX -90.3% (-68.9%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020252026$0$10
MNDR XRTX

MNDR vs XRTX: by the numbers

  • •XRTX is the larger company ($484571 vs $30019 market cap).
  • •Both run net losses; XRTX's is the smaller (0.00% vs -44.25% net margin).

Metrics side by side

Valuation

MetricMNDRXRTX
P/B ratio0.000.09

Profitability

MetricMNDRXRTX
Gross margin-11.45%0.00%
Operating margin-46.36%0.00%
Net margin-44.25%0.00%
ROE-124.31%-68.17%
ROIC-116.42%-71.43%

Growth (annualized)

MetricMNDRXRTX
Total return CAGR (5Y)N/A-63.52%

Go deeper

Full MNDR analysisFull XRTX analysisInteractive comparison tool

Dig into the metrics

Mobile-health Network Solutions Class A Ordinary Shares ROEXORTX Therapeutics ROEMobile-health Network Solutions Class A Ordinary Shares operating marginXORTX Therapeutics operating marginMobile-health Network Solutions Class A Ordinary Shares revenue growthXORTX Therapeutics revenue growthMobile-health Network Solutions Class A Ordinary Shares free cash flowXORTX Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.